SCHEMBL8291753

SCHEMBL8291753

CCS(=O)(=O)N(C)C[C@@H](NC(=O)N[C@@H]1C(=O)N2C[C@@H]3C[C@@H]3[C@H]2C(=O)N[C@H](C(=O)C(=O)NC2CC2)CCCCCCCO[C@H]1C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12606687 0.89 — —
SCHEMBL12607432 0.81 — —
SCHEMBL8291706 0.80 CPB2 (0.30) —
SCHEMBL8052409 0.77 CPB2 (0.31) —
SCHEMBL13685594 0.77 CPB2 (0.31) —
SCHEMBL12606696 0.75 — —
SCHEMBL12606685 0.74 — —
SCHEMBL8050247 0.74 — —
SCHEMBL8045685 0.72 — —
SCHEMBL8046972 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005030796-A1 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE SCHERING CORPORATION (US) 2005-04-07 — — WO disclosed
Send feedback